Esophageal Cancer  >>  Phase 3
Welcome,         Profile    Billing    Logout  

3 Trials

   Remove Filter

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Esophageal Cancer
NCT02461043: Adjuvant Chemotherapy With Paclitaxel and Cisplatin in Lymph Node-Positive Adjuvant Chemotherapy in the Treatment of the Lymph Node Positive Thoracic Esophageal Squamous Cell Carcinoma

Recruiting
3
386
RoW
paclitaxel; cisplatin, radiation
Chinese Academy of Medical Sciences
Esophageal Cancer
12/20
12/23
SCOPE2, NCT02741856 / 2015-001740-11: Study of Chemoradiotherapy in Oesophageal Cancer Including PET Response and Dose Escalation

Recruiting
2/3
584
Europe
Carboplatin, Paclitaxel, Cisplatin, Capecitabine, Radiotherapy
Lisette Nixon, Cancer Research UK
Oesophageal Cancer
04/21
04/23
Esostrate, NCT02551458: Comparison of Systematic Surgery Versus Surveillance and Rescue Surgery in Operable Oesophageal Cancer With a Complete Clinical Response to Radiochemotherapy

Terminated
2/3
188
Europe
Systematic surgery, Surveillance and rescue surgery in cases of resectable loco-regional recurrence
Centre Hospitalier Universitaire Dijon
Epidermoid Carcinoma or, Adenocarcinoma of the Thoracic Oesophagus or, Adenocarcinoma of the Oesogastric Junction (Siewert Type I or II), Stage cT2 N1-3 M0 or cT3-T4a N0 or N1-3 M0
03/23
 

Download Options